Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
There is more to cancer immunotherapy than cytotoxic T cells.
In animal studies, introducing intestinal bacteria can promote anti-tumor immunity in the colon.
Severe short-term caloric restriction is safe for cancer patients and is associated with activation of immune responses.
The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.
Evidence is growing that contracting SARS-CoV-2 is generally as effective as vaccination at preventing COVID-19.
Younger adults and stem cell transplant recipients are at highest risk for measles and mumps.
Certain types of cancer treatment can lead to inadequate immune response.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
Research suggests protective effect of natural infection or vaccination is likely to be persistent.
While the United States is getting closer to this point, most health experts caution, it still has ground to cover.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
This is a good time to talk about how sleep can affect the body’s immune response to a vaccination.
The coronavirus vaccines are safe and should be effective even for people with advanced cancer.
More than 95% of people who recovered from COVID-19 had durable immune system memory up to eight months after infection.
Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.